Author Jean-François Gélinas was omitted as an author in the published article.
The authors apologize for this error and state that this does not change the scientific conclusions of the article in any way. All authors agreed to the correction.
The corrected author list appears below (there are no changes to the affiliation list):
Jean-Sébastien Delisle1,2,3,4*, Diane Fournier5*, Kim Santerre4, Samuel Rochette5, Ma'n H. Zawati4.6, Maude Dumont-Lagacé5,7, Simon Turcotte4,8,9, Jason Robert Guertin4,10,11,12, Patrick Vermette4,13,14, Jacques P. Tremblay4,15,16, Maxime Parisotto17, Christian Beauséjour4,18,19, Jean-François Gélinas4,20 Louisa Petropoulos20, Natasha Kekre21, Stéphanie Michaud22, Mélanie Dieudé23,24,25*.
In the published article, the author contribution and conflict of interest statements were missing the information of author Jean-François Gélinas, who was erroneously excluded from the author list.
A correction has been made to the section Author Contributions to add the contributions of Jean-François Gélinas. The added sentence appears below:
“J-FG: Data curation, Formal analysis, Writing – review and editing.”
A correction has also been made to the section Conflict of Interest to add information on author Jean-François Gélinas. This sentence previously stated :
“LP was employed by Centre C3i Inc.”
The corrected sentence appears below:
“J-FG is and LP was employed by Centre C3i Inc.”
The original article has been updated.
Statements
Publisher’s note
All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article, or claim that may be made by its manufacturer, is not guaranteed or endorsed by the publisher.
Summary
Keywords
immune effector cell immunotherapy, research funding, economic evaluation, ethics, biological drug approval, cell and tissue manufacturing
Citation
Delisle J-S, Fournier D, Santerre K, Rochette S, Zawati MH, Dumont-Lagacé M, Turcotte S, Guertin JR, Vermette P, Tremblay JP, Parisotto M, Beauséjour C, Gélinas J-F, Petropoulos L, Kekre N, Michaud S and Dieudé M (2025) Correction: Harnessing the promises of cell therapy, gene therapy, and regenerative medicine in Québec, Canada. Front. Med. 12:1710876. doi: 10.3389/fmed.2025.1710876
Received
22 September 2025
Accepted
29 September 2025
Published
17 October 2025
Approved by
Frontiers Editorial Office, Frontiers Media SA, Switzerland
Volume
12 - 2025
Updates
Copyright
© 2025 Delisle, Fournier, Santerre, Rochette, Zawati, Dumont-Lagacé, Turcotte, Guertin, Vermette, Tremblay, Parisotto, Beauséjour, Gélinas, Petropoulos, Kekre, Michaud and Dieudé.
This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.
*Correspondence: Jean-Sébastien Delisle js.delisle@umontreal.caDiane Fournier diane.fournier@hema-quebec.qc.caMélanie Dieudé melanie.dieude@hema-quebec.qc.ca
Disclaimer
All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article or claim that may be made by its manufacturer is not guaranteed or endorsed by the publisher.